Ciprofloxacin-resistant Salmonella Kentucky in travelers [7]

Emerging Infectious Diseases

Volumn 12, Issue 10, 2006, Pages 1611-1612

  Weill, François Xavier ^a   Bertrand, Sophie ^b   Guesnier, Françoise ^a   Baucheron, Sylvie ^c   Grimont, Patrick A D ^a   Cloeckaert, Axel ^c  

^a INSTITUT PASTEUR   (France)

^b SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^c CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; GENTAMICIN; NALIDIXIC ACID; QUINOLONE DERIVATIVE; SULFONAMIDE; TETRACYCLINE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; DRUG SENSITIVITY; GEOGRAPHIC DISTRIBUTION; HUMAN; LETTER; MINIMUM INHIBITORY CONCENTRATION; MUTATIONAL ANALYSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; SALMONELLA ENTERICA; SALMONELLOSIS; SEROTYPING; TRAVEL;

EID: 33750012426     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1210.060589     Document Type: Letter

References (10)

1. Olsen SJ, DeBess EE, McGivern TE, Marano N, Eby T, Mauvais S, et al. A nosocomial outbreak of fluoroquinolone-resistant Salmonella infection. N Engl J Med. 2001;344:1572-9.
2. Baucheron S, Imberechts H, Chaslus-Dancla E, Cloeckaert A. The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar Typhimurium phage type DT204. Microb Drug Resist. 2002;8:281-9.
3. Casin I, Breuil J, Darchis JP, Guelpa C, Collatz E. Fluoroquinolone resistance linked to GyrA, GyrB, and ParC mutations in Salmonella enterica Typhimurium isolates in humans. Emerg Infect Dis. 2003;9:1455-7.
4. Ling JM, Chan EW, Lam AW, Cheng AF. Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong. Antimicrob Agents Chemother. 2003;47:3567-73.
5. Hsueh PR, Teng LJ, Tseng SP, Chang CF, Wan JH, Yan JJ, et al. Ciprofloxacin-resistant Salmonella enterica Typhimurium and Choleraesuis from pigs to humans, Taiwan. Emerg Infect Dis. 2004;10:60-8.
6. Marimon JM, Gomariz M, Zigorraga C, Cilla G, Perez-Trallero E. Increasing prevalence of quinolone resistance in human nontyphoid Salmonella enterica isolates obtained in Spain from 1981 to 2003. Antimicrob Agents Chemother. 2004;48:3789-93.
7. Izumiya H, Mori K, Kurazono T, Yamaguchi M, Higashide M, Konishi N, et al. Characterization of isolates of Salmonella enterica serovar Typhimurium displaying high-level fluoroquinolone resistance in Japan. J Clin Microbiol. 2005;43:5074-9.
8. Baucheron S, Chaslus-Dancla E, Cloeckaert A, Chiu CH, Butaye P. High-level resistance to fluoroquinolones linked to mutations in gyrA, parC, and parE in Salmonella enterica serovar Schwarzengrund isolates from humans in Taiwan. Antimicrob Agents Chemother. 2005;49:862-3.
9. Weill FX, Guesnier F, Guibert V, Timinouni M, Demartin M, Polomack L, et al. Multidrug resistance in Salmonella enterica serotype Typhimurium from humans in France (1993 to 2003). J Clin Microbiol. 2006;44:700-8.
10. Molla B, Berhanu A, Muckle A, Cole L, Wilkie E, Kleer J, et al. Multidrug resistance and distribution of Salmonella serovars in slaughtered pigs. J Vet Med B Infect Dis Vet Public Health. 2006;53:28-33.